MX2022011651A - Composicion farmaceutica para tratamiento de diabetes. - Google Patents
Composicion farmaceutica para tratamiento de diabetes.Info
- Publication number
- MX2022011651A MX2022011651A MX2022011651A MX2022011651A MX2022011651A MX 2022011651 A MX2022011651 A MX 2022011651A MX 2022011651 A MX2022011651 A MX 2022011651A MX 2022011651 A MX2022011651 A MX 2022011651A MX 2022011651 A MX2022011651 A MX 2022011651A
- Authority
- MX
- Mexico
- Prior art keywords
- treating diabetes
- administration
- dapansutrile
- directed
- subject
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- LQFRYKBDZNPJSW-UHFFFAOYSA-N 3-methylsulfonylpropanenitrile Chemical compound CS(=O)(=O)CCC#N LQFRYKBDZNPJSW-UHFFFAOYSA-N 0.000 abstract 1
- 229950002291 dapansutrile Drugs 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La presente invención está dirigida a una composición y método para tratar diabetes. El método comprende administrar a un sujeto que lo necesite dapansutrilo, o un solvato del mismo farmacéuticamente aceptable, en una cantidad eficaz. La administración oral es una vía de administración preferida.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062994486P | 2020-03-25 | 2020-03-25 | |
PCT/US2021/023497 WO2021194975A1 (en) | 2020-03-25 | 2021-03-22 | Method for treating diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022011651A true MX2022011651A (es) | 2022-10-13 |
Family
ID=77890597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022011651A MX2022011651A (es) | 2020-03-25 | 2021-03-22 | Composicion farmaceutica para tratamiento de diabetes. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20230028615A1 (es) |
EP (1) | EP4132505A4 (es) |
JP (1) | JP2023518829A (es) |
CN (1) | CN115279363A (es) |
AU (1) | AU2021244313A1 (es) |
MX (1) | MX2022011651A (es) |
WO (1) | WO2021194975A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115089572A (zh) * | 2022-07-18 | 2022-09-23 | 南通大学 | 一种化合物olt1177在制备治疗2型糖尿病药物制剂中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018129347A1 (en) * | 2017-01-06 | 2018-07-12 | Olatec Therapeutics Llc | Methods for treating cardiovascular diseases |
WO2018204764A1 (en) * | 2017-05-05 | 2018-11-08 | Camp4 Therapeutics Corporation | Identification and targeted modulation of gene signaling networks |
ES2949404T3 (es) * | 2017-07-24 | 2023-09-28 | Novartis Ag | Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP |
-
2021
- 2021-03-22 WO PCT/US2021/023497 patent/WO2021194975A1/en unknown
- 2021-03-22 AU AU2021244313A patent/AU2021244313A1/en active Pending
- 2021-03-22 MX MX2022011651A patent/MX2022011651A/es unknown
- 2021-03-22 CN CN202180020954.7A patent/CN115279363A/zh active Pending
- 2021-03-22 EP EP21774979.5A patent/EP4132505A4/en active Pending
- 2021-03-22 JP JP2022557164A patent/JP2023518829A/ja active Pending
-
2022
- 2022-09-22 US US17/934,526 patent/US20230028615A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4132505A4 (en) | 2024-04-24 |
JP2023518829A (ja) | 2023-05-08 |
WO2021194975A1 (en) | 2021-09-30 |
EP4132505A1 (en) | 2023-02-15 |
AU2021244313A1 (en) | 2022-11-17 |
CN115279363A (zh) | 2022-11-01 |
US20230028615A1 (en) | 2023-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022006865A (es) | Tetrahidrofuranos sustituidos como moduladores de canales de sodio. | |
NI201100147A (es) | Métodos para tratar infartos agudos de miocardio y trastornos relacionados. | |
MX2021009199A (es) | Conjugado de farmaco de dos ligandos y uso del mismo. | |
WO2021168483A3 (en) | Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors | |
MX2022015629A (es) | Uso de vibegron para tratar vejiga sobreactiva. | |
PH12021550713A1 (en) | Medicament for the treatment of chronic cough | |
AR119159A1 (es) | Tratamientos de angioedema | |
MX2021009539A (es) | Derivado del profarmaco 6-oxo-1,6-dihidropiridazina, metodo de preparacion del mismo y aplicacion del mismo en medicina. | |
MX2022000430A (es) | Administracion de agonista de sting e inhibidores de puntos de control. | |
MX2022000143A (es) | Metodos novedosos. | |
PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
AU2020278236A8 (en) | Methods of treating Sjögren's Syndrome using a Bruton's tyrosine kinase inhibitor | |
MX2022007911A (es) | Procedimiento de tratamiento de una infeccion virica usando un agonista de tlr7. | |
MX2022011101A (es) | Formulaciones de anticuerpos anti protofibrillas beta amiloide de alta concentracion y metodos de uso de las mismas. | |
MX2022011651A (es) | Composicion farmaceutica para tratamiento de diabetes. | |
MX2021007330A (es) | Composiciones y métodos terapéuticos para tratar cáncer usando ácido 6, 8-bis-benciltio-octanoico y un inhibidor de autofagia. | |
MX2022003845A (es) | Tratamientos cognitivos medicinales. | |
MX2022012001A (es) | Tratamiento preventivo de la migra?a. | |
MX2021015561A (es) | Composiciones farmaceuticas que contienen dapansutrilo. | |
MX2022005596A (es) | Regimen de dosificacion para agentes anti-dll3. | |
MX2022010407A (es) | Forma de dosis oral de rápida dispersión de rimegepant. | |
MX2022009898A (es) | Compuesto de dihidronaftiridinona y metodo de preparacion del mismo y uso medico del mismo. | |
MX2021015338A (es) | Composicion que comprende pridopidina y un analogo de la misma para el tratamiento de la enfermedad de huntington y sintomas de la misma. | |
EA202193211A1 (ru) | Лечение синуклеопатий | |
MX2022006414A (es) | Vacuna triple contra avibacterium paragallinarum y el virus de la encefalomielitis aviar y el virus de la viruela aviar. |